Testing effectiveness (Phase 2)Study completedNCT00621322
What this trial is testing
Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults
Who this might be right for
Tuberculosis
GlaxoSmithKline 180
Showing 3 of 3 results